PharmaResearch Co., Ltd. is a biopharmaceutical company leading the regenerative Rx, OTC, Medical Device, Cosmetics and Dietary supplement technology and their market.
KOSPI closed down 0.34% at 2556.61, awaiting US Big Tech earnings. Tariff uncertainties persist. Foreign and institutional investors sold, while individuals bought.
Pharma Research strengthens sibling management through split
Pharma Research announces corporate split, strengthening sibling management. Concerns raised about controlling shareholder's power increase. Market reacts negatively to the news.
PharmaResearch defends its split ratio, citing professional review and tax considerations. The company plans to offer equal opportunities to all shareholders in future capital increases.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.